Physician
Weldon-Linne, C. Michael
Weldon-Linne, C. Michael was paid $581K by Medicaid between Jan 2018 and Dec 2019, across 88 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 9.3% of everything it billed.
33Billing provider infoWELDON-LINNE, C. MICHAEL
PARK RIDGE, IL 60068
PARK RIDGE, IL 60068
33aNPI1598757965assigned 08/22/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$581K
24GClaims151,723
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2019
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#78 of 398
Median peer was paid$66K
This provider vs. median8.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 73,350 | $273K | |
| 2019 | 78,373 | $308K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.3% | 19,235 | 10,565 | $54K |
| 80053 | Comprehensive metabolic panel | 8.1% | 9,371 | 6,277 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.8% | 11,254 | 5,425 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.2% | 1,521 | 1,379 | $36K |
| 87641 | 4.2% | 1,108 | 912 | $25K | |
| 82330 | 3.9% | 3,557 | 905 | $23K | |
| 82805 | 3.6% | 3,969 | 989 | $21K | |
| 83605 | 3.5% | 5,100 | 1,658 | $21K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.4% | 870 | 814 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.3% | 867 | 811 | $19K |
| 83735 | 3.2% | 5,690 | 2,664 | $19K | |
| 87040 | 2.9% | 2,411 | 918 | $17K |
76 more codes
| 84484 | 2.7% | 4,373 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.7% | 1,847 | $16K |
| 84703 | 2.0% | 3,373 | $12K | |
| 85027 | 1.6% | 3,383 | $9K | |
| 83690 | 1.6% | 2,734 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 1,895 | $9K |
| 86901 | 1.5% | 3,719 | $9K | |
| 86850 | 1.4% | 2,979 | $8K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.4% | 47 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 1,079 | $8K |
| 85730 | 1.3% | 2,734 | $8K | |
| 82803 | 1.2% | 1,304 | $7K | |
| 81001 | 1.2% | 5,070 | $7K | |
| 82375 | 1.1% | 3,189 | $7K | |
| 86900 | 1.1% | 3,713 | $6K | |
| 83880 | 1.1% | 857 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.0% | 275 | $6K |
| 85610 | <1% | 3,096 | $6K | |
| 87186 | <1% | 882 | $5K | |
| 83050 | <1% | 3,274 | $4K | |
| 84100 | <1% | 2,551 | $4K | |
| 87806 | <1% | 342 | $3K | |
| 82947 | <1% | 2,684 | $3K | |
| 85379 | <1% | 754 | $3K | |
| 82435 | <1% | 2,501 | $3K | |
| 85018 | <1% | 3,205 | $3K | |
| 82550 | <1% | 1,029 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 69 | $2K |
| 84295 | <1% | 2,544 | $2K | |
| 84702 | <1% | 630 | $2K | |
| 87077 | <1% | 672 | $2K | |
| 86140 | <1% | 910 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 50 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 765 | $2K |
| 80061 | Lipid panel | <1% | 806 | $2K |
| 87075 | <1% | 304 | $2K | |
| 87210 | <1% | 851 | $2K | |
| 82247 | <1% | 895 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 240 | $2K |
| 87070 | <1% | 581 | $2K | |
| 81003 | <1% | 1,601 | $2K | |
| 82962 | <1% | 1,936 | $2K | |
| 80076 | <1% | 491 | $2K | |
| 87081 | <1% | 503 | $1K | |
| 86592 | <1% | 654 | $1K | |
| 82248 | <1% | 849 | $1K | |
| 87205 | <1% | 664 | $1K | |
| 82570 | <1% | 527 | $1K | |
| 87088 | <1% | 202 | $1K | |
| 85046 | <1% | 420 | $912.83 | |
| 84550 | <1% | 475 | $761.80 | |
| 85014 | <1% | 754 | $731.74 | |
| 83615 | <1% | 309 | $658.53 | |
| 81025 | <1% | 494 | $617.62 | |
| 82607 | <1% | 96 | $567.20 | |
| 85652 | <1% | 412 | $553.54 | |
| 82150 | <1% | 154 | $532.03 | |
| 83550 | <1% | 139 | $510.77 | |
| 82728 | <1% | 159 | $489.71 | |
| 84156 | <1% | 445 | $486.64 | |
| 83540 | <1% | 164 | $467.31 | |
| 84145 | <1% | 458 | $325.50 | |
| 85384 | <1% | 115 | $310.94 | |
| 80164 | <1% | 62 | $274.66 | |
| 82746 | <1% | 47 | $260.78 | |
| 80202 | <1% | 38 | $243.70 | |
| 87015 | <1% | 58 | $190.80 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $186.29 |
| 84439 | <1% | 32 | $141.76 | |
| 82272 | <1% | 124 | $103.68 | |
| 86308 | <1% | 14 | $33.42 | |
| 82565 | <1% | 12 | $23.92 | |
| 87147 | <1% | 13 | $20.80 | |
| 80320 | 0% | 1,980 | $0.00 | |
| 80329 | 0% | 40 | $0.00 | |
| 86923 | 0% | 110 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.